|
Roche acquires innovatis AG to complement its product portfolio
|
17 March 2009 |
|
Roche Annual General Meeting: dividend raised by 9 percent
|
11 March 2009 |
|
Roche increases offer price for Genentech shares to US$ 93 per share
|
09 March 2009 |
|
Immune-boosting effect of Pegasys provides patients with the chance for a clinical cure
|
17 February 2009 |
|
Strong operating results for Roche in 2008
|
06 February 2009 |
|
Roche Announces Interim Results from a Phase III ATLAS Study
|
03 February 2009 |
|
Foundation-laying ceremony for new R&D building at Roche Basel
|
24 January 2009 |
|
Roche and Axiogenesis Enter into Co-Development and Marketing Agreement
|
10 December 2008 |
|
Roche signs definitive agreement to acquire Memory Pharmaceuticals
|
01 December 2008 |
|
Tarceva brings new hope to patients with advanced non-small cell lung cancer
|
12 November 2008 |
|
Roche posts sustained double-digit sales growth for the first nine months of 2008
|
25 October 2008 |
|
Roche invests 215 million Swiss francs in diagnostics facility at Penzberg
|
02 October 2008 |
|
Divestment of four Roche pharmaceutical products to Meda
|
15 August 2008 |
|
First interleukin-6 inhibitor (IL-6) to offer new therapeutic option for rheumatoid arthritis
|
31 July 2008 |
|
Roche's tender offer to increase ownership stake in Chugai successful
|
26 June 2008 |
|
Actemra inhibits joint damage and improves physical function of patients with Rheumatoid Arthritis
|
10 May 2008 |
|
Roche fully acquires privately-owned biotech company Piramed
|
16 April 2008 |
|
Record operating results for Roche again in 2007
|
04 February 2008 |
|
Roche invests 430 million Swiss francs at sites in Germany and Switzerland
|
22 January 2008 |
|
Roche engages in four additional AIDS Technology Transfers
|
10 January 2008 |